SCHEMBL4910441

SCHEMBL4910441

CC1CCn2nc(C(=O)O)cc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.43
POLB P06746 3/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
NR4A1 P22736 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ACHE P22303 1/20 0.37
RIPK1 Q13546 1/20 0.36
TP53 P04637 2/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
MITF O75030 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HCAR2 Q8TDS4 2/20 0.35
KMT2A Q03164 1/20 0.35
HTT P42858 1/20 0.35
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6383954 1.00 USP2 (0.43) USP2POLBKDM4EGAANR4A1
SCHEMBL31389863 0.81 ATM (0.43) POLBGAATP53KMT2AALDH1A1
SCHEMBL21295147 0.78 ALDH1A1 (0.36) POLBKDM4EHSD17B10RIPK1HCAR2
SCHEMBL4967402 0.78 USP2 (0.37) USP2POLBKDM4EGAANR4A1
SCHEMBL31389644 0.75 POLB (0.37) POLBGAARIPK1HCAR2KMT2A
SCHEMBL26176612 0.75 L3MBTL1 (0.37) USP2KDM4EGAAHSD17B10TP53
SCHEMBL31389779 0.74 RIPK1 (0.47) USP2POLBKDM4EGAANR4A1
SCHEMBL31389530 0.73 DRD4 (0.33) USP2POLBKDM4EGAANR4A1
SCHEMBL6858151 0.72 POLB (0.37) POLBHCAR2HTTALDH1A1ESR1
SCHEMBL1815818 0.71 KMO (0.42) POLBRIPK1HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778685-B1 INDOLIZINE CARBOXAMIDES AND THE AZA AND DIAZA DERIVATIVES THEREOF SANOL ARZNEI SCHWARZ GMBH (DE) 2008-03-26 EP disclosed
US-20080051409-A1 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof SCHWARZ PHARMA AG (DE) 2008-02-28 US disclosed
EP-1778685-A1 INDOLIZINE CARBOXAMIDES AND THE AZA AND DIAZA DERIVATIVES THEREOF SCHWARZ PHARMA AG (DE) 2007-05-02 EP disclosed
WO-2006015737-A1 INDOLIZINE CARBOXAMIDES AND THE AZA AND DIAZA DERIVATIVES THEREOF SCHWARZ PHARMA AG (DE) 2006-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051409-A1 Indolizine Carboxamides and Aza and Diaza Derivatives Thereof GRIN2A, GRIN2C, GRIN1 USP2 3865/4885POLB 4655/4885KDM4E 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.